The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Rukavishnikov G.V.

Bekhterev National Medical Research Center for Psychiatry and Neurology

Boring, sad... and painful!

Authors:

Rukavishnikov G.V.

More about the authors

Journal: Non Nocere. New Therapeutic Journal. 2025;(8): 56‑59

Read: 98 times

To cite this article:

Rukavishnikov GV. Boring, sad... and painful! Non Nocere. New Therapeutic Journal. 2025;(8):56‑59. (In Russ.)

References:

  1. Institute of Health Metrics and Evaluation. Results from the 2021 Global Burden of Disease (GBD) study. https://vizhub.healthdata.org/gbd-results/
  2. Berk M, Köhler-Forsberg O, Turner M, et al. Comorbidity between major depressive disorder and physical diseases: a comprehensive review of epidemiology, mechanisms and management. World Psychiatry. 2023 Oct;22(3):366-387.  https://doi.org/10.1002/wps.21110
  3. Arnaud AM, Brister TS, Duckworth K, et al. Impact of Major Depressive Disorder on Comorbidities: A Systematic Literature Review. J Clin Psychiatry. 2022 Oct 19;83(6):21r14328. https://doi.org/10.4088/JCP.21r14328
  4. Rogers D, Pies R. General medical with depression drugs associated. Psychiatry (Edgmont). 2008 Dec;5(12):28-41. 
  5. Elgellaie A, Larkin T, Kaelle J, Mills J, Thomas S. Plasma prolactin is higher in major depressive disorder and females, and associated with anxiety, hostility, somatization, psychotic symptoms and heart rate. Compr Psychoneuroendocrinol. 2021 Mar 20;6:100049. https://doi.org/10.1016/j.cpnec.2021.100049
  6. Hoare E, Collins S, Marx W, et al. Universal depression prevention: An umbrella review of meta-analyses. J Psychiatr Res. 2021 Dec;144:483-493.  https://doi.org/10.1016/j.jpsychires.2021.10.006
  7. Rukavishnikov GV, Kibitov AO, Mazo G, Neznanov NG. Genetic comorbidity of depression and somatic disorders. S.S. Korsakov Journal of Neurology and Psychiatry. 2019;119(1):89-96. (In Russ.) https://doi.org/10.17116/jnevro201911901189
  8. Rousset L, Halioua B. Stress and psoriasis. Int J Dermatol. 2018 Oct;57(10):1165-1172. https://doi.org/10.1111/ijd.14032
  9. Meng X, Brunet A, Turecki G, et al. Risk factor modifications and depression incidence: a 4-year longitudinal Canadian cohort of the Montreal Catchment Area Study. BMJ Open. 2017;7:e015156. https://doi.org/10.1136/bmjopen-2016-015156
  10. Alshaya DS. Genetic and epigenetic factors associated with depression: An updated overview. Saudi J Biol Sci. 2022 Aug;29(8):103311. https://doi.org/10.1016/j.sjbs.2022.103311
  11. Czarny P, Wigner P, Galecki P, Sliwinski T. The interplay between inflammation, oxidative stress, DNA damage, DNA repair and mitochondrial dysfunction in depression. Prog Neuropsychopharmacol Biol Psychiatry. 2018 Jan 3;80(Pt C):309-321.  https://doi.org/10.1016/j.pnpbp.2017.06.036
  12. Kumar A, Pramanik J, Goyal N, et al. Gut Microbiota in Anxiety and Depression: Unveiling the Relationships and Management Options. Pharmaceuticals (Basel). 2023 Apr 9;16(4):565.  https://doi.org/10.3390/ph16040565
  13. Hermesdorf M, Berger K, Baune BT, Wellmann J, Ruscheweyh R, Wersching H. Pain Sensitivity in Patients With Major Depression: Differential Effect of Pain Sensitivity Measures, Somatic Cofactors, and Disease Characteristics. J Pain. 2016 May;17(5):606-616.  https://doi.org/10.1016/j.jpain.2016.01.474
  14. Trivedi MH. The link between depression and physical symptoms. Prim Care Companion J Clin Psychiatry. 2004;6(Suppl 1):12-16. 
  15. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983 Jun;67(6):361-370.  https://doi.org/10.1111/j.1600-0447.1983.tb09716.x
  16. Samushiya MA, Al-Shukri AS, Baranov II, et al. Development of a diagnostic and treatment algorithm for anxiety associated with somatic pathology in patients in general clinical practice. Resolution of the expert council. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;125(1):62-69. (In Russ.) https://doi.org/10.17116/jnevro202512501162
  17. Bekhuis E, Boschloo L, Rosmalen JG, Schoevers RA. Differential associations of specific depressive and anxiety disorders with somatic symptoms. J Psychosom Res. 2015 Feb;78(2):116-122.  https://doi.org/10.1016/j.jpsychores.2014.11.007
  18. Alblooshi S, Taylor M, Gill N. Does menopause elevate the risk for developing depression and anxiety? Results from a systematic review. Australas Psychiatry. 2023 Apr;31(2):165-173.  https://doi.org/10.1177/10398562231165439
  19. Antonelli A, Giannini A, Chedraui P, et al. Mood disorders and hormonal status across women’s life: a narrative review. Gynecol Endocrinol. 2022 Dec;38(12):1019-1027. https://doi.org/10.1080/09513590.2022.2149730
  20. Parissis J, Fountoulaki K, Paraskevaidis I, Kremastinos DT. Sertraline for the treatment of depression in coronary artery disease and heart failure. Expert Opin Pharmacother. 2007 Jul;8(10):1529-1537. https://doi.org/10.1517/14656566.8.10.1529
  21. Gao SY, Wu QJ, Sun C, et al. Selective serotonin reuptake inhibitor use during early pregnancy and congenital malformations: a systematic review and meta-analysis of cohort studies of more than 9 million births. BMC Med. 2018 Nov 12;16(1):205.  https://doi.org/10.1186/s12916-018-1193-5
  22. Meyerowitz W, Jaramillo JDC. Sertraline treatment and weight loss. Current Therapeutic Research. 1994;55(10):1176-1181. https://doi.org/10.1016/S0011-393X(05)80258-9

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.